3 global pharma giants, NUS and A*Star team up for manufacturing innovation
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
[SINGAPORE] Pharmaceutical manufacturing in Singapore is set to benefit from industry partnerships, with Minister for Trade and Industry (Industry) S Iswaran announcing the launch on Tuesday of the Pharma Innovation Programme Singapore.
The industry development scheme is a tie-up between the National University of Singapore, the Agency for Science, Technology and Research (A*Star) and three global drug giants - GlaxoSmithKline, Pfizer and MSD.
It will focus on areas such as continuous manufacturing, bio-catalysis, process analytical technology and advanced process control.
Full Story Here.
Copyright SPH Media. All rights reserved.
TRENDING NOW
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
Singaporeans can now buy record amount of yen per Singdollar
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Keppel DC Reit posts 13.2% higher Q1 DPU of S$0.02833 on strong portfolio performance
